• Manufacturing activities underway for a further two planned launches during FY25
I suspect one is for the efinaconazole topical solution which has been approved by the FDA.
- Forums
- ASX - By Stock
- ACR
- Ann: Quarterly Activities Report and Appendix 4C - June 2024
Ann: Quarterly Activities Report and Appendix 4C - June 2024, page-8
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
Add ACR (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.69M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 434 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 17258 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 434 | 0.054 |
2 | 16865 | 0.053 |
2 | 293669 | 0.052 |
3 | 119539 | 0.051 |
2 | 217490 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 17258 | 1 |
0.059 | 18000 | 1 |
0.060 | 670 | 1 |
0.061 | 100000 | 1 |
0.062 | 116100 | 2 |
Last trade - 16.12pm 04/10/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
Day chart unavailable